Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

Clinical trial NCT01747577 · COMPLETED

Trial details

NCT number: NCT01747577
Sponsor: Astellas Pharma Korea, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Overactive Bladder Benign Prostate Hyperplasia Transurethral Resection of Prostate Photoselective Vaporization Prostatectomy

Start date: 2012-12-04
Primary completion: 2013-10-24
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.